References
- 1GoldsteinL, DjaldettiR, BenningerF Anti-Yo, chorea and hemiballismus: a case report. J Clin Neurosci 2017;42:113–114. doi: 10.1016/j.jocn.2017.03.04528372903
- 2AydinD, SomnierF, LassenLH Paraneoplastic choreoathetosis in a patient with small cell lung carcinoma and anti-CRMP5/CV2: a case report. Case Rep Neurol 2016;8(1):16–19. doi: 10.1159/00044352226889151
- 3HonnoratJ, Cartalat-CarelS, RicardD, CamdessancheJP, CarpentierAF, RogemondV, et al Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies. J Neurol Neurosurg Psychiatry 2009;80(4):412–416. doi: 10.1136/jnnp.2007.13801618931014
- 4ViglianiMC, HonnoratJ, AntoineJC, VitalianiR, GiomettoB, PsimarasD, et al Chorea and related movement disorders of paraneoplastic origIn: the PNS EuroNetwork experience. J Neurol 2011;258(11):2058–2068. doi: 10.1007/s00415-011-6074-121559939
- 5KangY, JahngS, NaDL Seoul neuropsychological screening battery, 2nd edition (SNSB-II). Seoul: Human Brain Research & Consulting Co; 2012.
- 6KangIW, BeomIG, ChoJY, SonHR Accuracy of Korean-mini-mental status examination based on Seoul neuro-psychological screening battery II results. Korean J Fam Med 2016;37(3):177–181. doi: 10.4082/kjfm.2016.37.3.17727274389
- 7SheikhJ, BrinkTL
Geriatric Depression Scale (GDS): recent evidence and development of a shorter version Clinical gerontology: a guide to assessment and intervention. New York: Haworth Press; 1986. doi: 10.1300/J018v05n01_09 - 8GamezJ, Lorenzo-BosquetC, Cuberas-BorrosG, CarmonaF, Hernandez-VaraJ, CastilloJ, et al Does reduced [(123)I]-FP-CIT binding in Huntington’s disease suggest pre-synaptic dopaminergic involvement? Clin Neurol Neurosurg 2010;112(10):870–875. doi: 10.1016/j.clineuro.2010.07.01420724066
- 9BelcastroV, PierguidiL, TambascoN, SironiL, SaccoL, CorsoA, et al Decreased contralateral putamen [I]FP-CIT SPECT uptake in hyperglycemic hemichorea-hemiballismus. Eur Neurol 2011;65(5):307–308. doi: 10.1159/00032730521576966
- 10HonnoratJ Early-onset immunotherapy by intravenous immunoglobulin and corticosteroids in well characterized onconeural-antibody-positive paraneoplastic neurological syndrome. Clin Exp Immunol 2014;178 Suppl 1:127–129. doi: 10.1111/cei.1253925546790
- 11ParsamehrB, MeseehaM, KoladeV CRMP5-positive paraneoplastic encephalitis in a patient with occult small cell lung cancer. Chest 2016;150(4):750A. doi: 10.1016/j.chest.2016.08.845
- 12Verhagen MetmanL, MorrisMJ, FarmerC, GillespieM, MosbyK, WuuJ, et al Huntington’s disease: a randomized, controlled trial using the NMDA-antagonist amantadine. Neurology 2002;59(5):694–699. doi: 10.1212/wnl.59.5.69412221159
- 13O’SuilleabhainP, DeweyRB
Jr A randomized trial of amantadine in Huntington disease. Archiv Neurol 2003;60(7):996–998. doi: 10.1001/archneur.60.7.996 - 14GalvanL, AndréVM, WangEA, CepedaC, LevineMS Functional differences between direct and indirect striatal output pathways in Huntington’s disease. J Huntington’s Dis 2012;1(1):17–25. doi: 10.3233/JHD-2012-12000925063187
- 15LancasterE, LaiM, PengX, HughesE, ConstantinescuR, RaizerJ, et al. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol 2010;9(1):67–76. doi: 10.1016/s1474-4422(09)70324-219962348